LIC turned 70 on 1 September 2026 and launched two plans that day, Bima Platinum and Jeevan Raksha. The stock fell on the announcement, slipped the next session again, then made back the loss on 3 September. Both plans opened for sale on 7 September. Because both are non-participating products, the launches read very differently for shareholders than for the people buying the policies.
How the LIC Share Price Moved After the Launch
LIC closed at ₹412.15 on the NSE on 1 September, down 1.40%, and at ₹411.25 on the BSE, down 1.45%. It fell again on 2 September. The recovery came on 3 September, when the stock closed at ₹416.90 on the NSE, up 2.12%, and at ₹420 on the BSE, up 2.82%. Intraday quotes during that session placed it near ₹416.75, a gain of 2.02% on the previous BSE close.
| Date (2026) | NSE close | BSE close |
| 1 Sept (launch day) | ₹412.15 (-1.40%) | ₹411.25 (-1.45%) |
| 2 Sept | ₹408.25 (-0.95%) | ₹408.50 (-0.67%) |
| 3 Sept | ₹416.90 (+2.12%) | ₹420.00 (+2.82%) |
| 4 Sept | ₹415.35 (-0.37%) | ₹415.25 (-1.13%) |
Where the Stock Stands after August’s ₹31,552 Crore Stake Sale
At ₹415.35, LIC trades about 11% below its 52-week high of ₹468.48 and roughly 15% above the low of ₹360.75. It is down about 4.6% over a year, and hovers just under a moving average band of ₹417 (200-day) to ₹421 (50-day). Much of the recent volatility traces to the August offer for sale, priced at a floor of ₹382. The stock fell 8.68% on 4 August when that discount was announced.
“Offer for Sale in the Life Insurance Corporation of India (LIC) closed with an overwhelming response from both retail and institutional investors. The issue was over-subscribed on both days and the Government exercised its entire green shoe option.”
— Secretary, DIPAM (@SecyDIPAM), 5 August 2026
What Bima Platinum and Jeevan Raksha offer buyers
Bima Platinum (Plan 770) is a non-par, non-linked individual plan mixing savings with cover. It accrues guaranteed additions of ₹70 per ₹1,000 of annual premium during the premium paying term, and pays a Booster Income Benefit of 70% of the basic sum assured at the end of the (PPT + 5th) year. The minimum sum assured is ₹3 lakh. Jeevan Raksha (Plan 894) is a pure risk plan for entry ages 18 to 45, with sums assured from ₹5 lakh to ₹24 lakh, and death benefits that are guaranteed and fixed.
Why non-par launches matter more to LIC shareholders
Surplus in the participating fund is split 90:10 between policyholders and shareholders from FY2024-25, under the policy LIC’s board approved in September 2021. Surplus from the non-participating fund goes to shareholders. Non-par made up 32.49% of individual APE in the June quarter, up from 30.34%, and the value of new business rose 61.32% to ₹3,136 crore.
“This is a direct outcome of our product diversification and distribution strategy.”
— R. Doraiswamy, CEO and MD, LIC, in the Q1 FY27 results release
What the share price does not change for an LIC policyholder
Profit after tax rose 22.81% to ₹13,492 crore in Q1 FY27 and total premium income grew 6.75% to ₹1,27,250 crore. The number that matters to a claimant is solvency, which improved to 2.42 from 2.17 against the 150% control level IRDAI prescribes. Guaranteed benefits on non-par plans are fixed by contract. Bonuses on participating policies come out of the participating fund’s valuation surplus after an actuarial valuation. Neither one moves when the stock does.
| Every time LIC’s stock swings, the same question reaches us: does this affect my policy? We answered it when LIC’s stock fell 8% during the government’s stake sale, and the answer has not changed with this rebound. MyRupia is an independent insurance guidance platform. We hold no insurer partnerships and earn nothing from commissions, so we can tell a reader when a new non-par plan is a poor fit for their goal. If Bima Platinum or Jeevan Raksha has been pitched to you, start with our guide to choosing an endowment plan. |
Disclaimer: This MyRupia article is for informational purposes only and is based on publicly available government, regulatory and industry sources. It should not be treated as investment, financial, tax, insurance, or legal advice. Information, examples, market data, and expert views mentioned in the article may change over time and should not be considered a recommendation to buy, sell, invest in, or surrender any financial product. Readers should evaluate their individual circumstances and consult a qualified financial professional before making decisions.